{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:29:44Z","timestamp":1794536984492,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ygyno.2022.02.018","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T07:39:27Z","timestamp":1645861167000},"page":"302-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fertility-sparing treatment for serous borderline ovarian tumors with extra-ovarian invasive implants: Analysis from the MITO14 study database"],"prefix":"10.1016","volume":"165","author":[{"given":"Francesca","family":"Falcone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Malzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierandrea","family":"De Iaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violante","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Raspagliesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia S.","family":"Losito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Greggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ygyno.2022.02.018_bb0005","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/ijc.23724","article-title":"Borderline ovarian tumors in Sweden 1960\u20132005: trends in incidence and age at diagnosis compared to ovarian cancer","volume":"123","author":"Sk\u00edrnisd\u00f3ttir","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.02.018_bb0010","series-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"Kurman","year":"2014"},{"key":"10.1016\/j.ygyno.2022.02.018_bb0015","series-title":"Female Genital Tumours. WHO Classification of Tumours","volume":"4","author":"WHO Classification of Tumours Editorial Board","year":"2020"},{"issue":"8","key":"10.1016\/j.ygyno.2022.02.018_bb0020","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.ejca.2013.01.035","article-title":"Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group","volume":"49","author":"du Bois","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2022.02.018_bb0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (\u22655-year) follow-up","volume":"29","author":"Longacre","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2022.02.018_bb0030","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0893-3952(22)04457-X","article-title":"Borderline epithelial tumors of the ovary","volume":"18","author":"Hart","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2022.02.018_bb0035","author":"National Comprehensive Cancer Network"},{"issue":"5","key":"10.1016\/j.ygyno.2022.02.018_bb0040","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.02.018_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/humupd\/dms047","article-title":"Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options","volume":"19","author":"Dara\u00ef","year":"2013","journal-title":"Reprod. Update"},{"issue":"10","key":"10.1016\/j.ygyno.2022.02.018_bb0050","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO;2-W","article-title":"Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis","volume":"62","author":"Bell","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2022.02.018_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/541842","article-title":"Diagnosis and management of peritoneal metastases from ovarian cancer","volume":"2012","author":"Halkia","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"issue":"2","key":"10.1016\/j.ygyno.2022.02.018_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.ygyno.2022.02.018_bb0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00428-016-2040-8","article-title":"Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria","volume":"470","author":"Hauptmann","year":"2017","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ygyno.2022.02.018_bb0070","article-title":"Results after conservative surgery of stage II\/III serous borderline ovarian tumors","author":"Gouy","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.02.018_bb0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.fertnstert.2015.03.038","article-title":"Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors","volume":"104","author":"Helpman","year":"2015","journal-title":"Fertil. Steril."},{"issue":"9","key":"10.1016\/j.ygyno.2022.02.018_bb0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200209000-00002","article-title":"Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion","volume":"26","author":"Prat","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.02.018_bb0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2011.01.009","article-title":"Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors","volume":"156","author":"Song","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"10","key":"10.1016\/j.ygyno.2022.02.018_bb0090","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1200\/JCO.2001.19.10.2658","article-title":"Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study","volume":"19","author":"Zanetta","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2022.02.018_bb0095","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.ejca.2013.01.035","article-title":"Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gyn\u00e4kologische Onkologie (AGO) Study Group","volume":"49","author":"du Bois","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2022.02.018_bb0100","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ygyno.2021.03.023","article-title":"Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database","volume":"161","author":"Falcone","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.02.018_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2013.11.006","article-title":"Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants","volume":"132","author":"Leary","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.02.018_bb0110","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","article-title":"Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence","volume":"13","author":"Morice","year":"2012","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2022.02.018_bb0115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1634\/theoncologist.2008-0263","article-title":"Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants","volume":"14","author":"Kane","year":"2009","journal-title":"Oncologist"},{"issue":"18","key":"10.1016\/j.ygyno.2022.02.018_bb0120","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1200\/JCO.2003.12.021","article-title":"Spontaneous regression of peritoneal implants in borderline ovarian tumor after salpingo-oophorectomy","volume":"21","author":"Morice","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2022.02.018_bb0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/hp.2000.8048","article-title":"Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators","volume":"31","author":"Seidman","year":"2000","journal-title":"Hum. Pathol."},{"issue":"11","key":"10.1016\/j.ygyno.2022.02.018_bb0130","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.pas.0000213294.81154.95","article-title":"The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent","volume":"30","author":"Silva","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.02.018_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1634\/theoncologist.2014-0144","article-title":"A meta-analysis on the impact of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors with invasive implants","volume":"20","author":"Vasconcelos","year":"2015","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.ygyno.2022.02.018_bb0140","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/humrep\/deq159","article-title":"Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up","volume":"25","author":"Palomba","year":"2010","journal-title":"Hum. Reprod."},{"issue":"10","key":"10.1016\/j.ygyno.2022.02.018_bb0145","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1177\/0300060519865850","article-title":"Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors","volume":"47","author":"Lu","year":"2019","journal-title":"J Int Med Res"},{"issue":"1","key":"10.1016\/j.ygyno.2022.02.018_bb0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/annonc\/mdp267","article-title":"Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary","volume":"21","author":"Uzan","year":"2010","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.02.018_bb0155","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.fertnstert.2009.11.033","article-title":"Surgery in advanced borderline tumors","volume":"94","author":"Vigan\u00f2","year":"2010","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.ygyno.2022.02.018_bb0160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.fertnstert.2006.07.1503","article-title":"Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study","volume":"87","author":"Fortin","year":"2007","journal-title":"Fertil. Steril."},{"issue":"12","key":"10.1016\/j.ygyno.2022.02.018_bb0165","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1093\/humrep\/del301","article-title":"Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours","volume":"21","author":"Basille","year":"2006","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.ygyno.2022.02.018_bb0170","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/1097-0142(20010715)92:2<320::AID-CNCR1325>3.0.CO;2-G","article-title":"Infertility treatment after conservative management of borderline ovarian tumors","volume":"92","author":"Beiner","year":"2001","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2022.02.018_bb0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000316264","article-title":"Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery","volume":"70","author":"Denschlag","year":"2010","journal-title":"Gynecol. Obstet. Investig."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:01:03Z","timestamp":1758772863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0090825822001287"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.02.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility-sparing treatment for serous borderline ovarian tumors with extra-ovarian invasive implants: Analysis from the MITO14 study database","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}